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Abstract
Background: The use of comorbidities in risk adjustment for health outcomes research is frequently necessary to
explain some of the observed variations. Medical charts reviews to obtain information on comorbidities is
laborious. Increasingly, electronic health care databases have provided an alternative for health services researchers
to obtain comorbidity information. However, the rates obtained from databases may be either over- or under-
reported. This study aims to (a) quantify the agreement between administrative data and medical charts review
across a set of comorbidities; and (b) examine the factors associated with under- or over-reporting of comorbidities
by administrative data.
Methods: This is a retrospective cross-sectional study of patients aged 55 years and above, hospitalized for
pneumonia at 3 acute care hospitals. Information on comorbidities were obtained from an electronic administrative
database and compared with information from medical charts review. Logistic regression was performed to
identify factors that were associated with under- or over-reporting of comorbidities by administrative data.
Results: The prevalence of almost all comorbidities obtained from administrative data was lower than that
obtained from medical charts review. Agreement between comorbidities obtained from medical charts and
administrative data ranged from poor to very strong (kappa 0.01 to 0.78). Factors associated with over-reporting of
comorbidities were increased length of hospital stay, disease severity, and death in hospital. In contrast, those
associated with under-reporting were number of comorbidities, age, and hospital admission in the previous 90
days.
Conclusions: The validity of using secondary diagnoses from administrative data as an alternative to medical
charts for identification of comorbidities varies with the specific condition in question, and is influenced by factors
such as age, number of comorbidities, hospital admission in the previous 90 days, severity of illness, length of
hospitalization, and whether inhospital death occurred. These factors need to be taken into account when relying
on administrative data for comorbidity information.
Background
Pre-existing conditions or comorbidities have been used
in risk adjustment for health outcomes research [1,2].
The number and type of comorbidities can have a sig-
nificant impact on patient outcomes and may explain
some of the observed variations [3-9]. Traditionally,
medical charts were used to obtain information on
comorbidities. This is a very laborious process. With the
advent of electronic health care databases that capture
financial data for the purpose of claims, such adminis-
trative data have provided an alternative for health
services researchers to obtain comorbidity information
for outcomes research [10-13].
While information obtained from administrative data-
bases has been used for risk adjustment [14-16], the evi-
dence on accuracy of secondary diagnoses from
administrative databases as a substitute for comorbid-
ities has been mixed [17-30]. Previous studies have
found that administrative databases tend to under-report
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others when compared with information from medical
charts [17-21,24,28-31]. Comorbidities that showed
better agreement between both data sources were solid
tumor [17], diabetes mellitus [25], connective tissue
disease [17,19], and chronic pulmonary disease [25]. The
conditions with poor agreement were renal disease [17],
dementia [17], hypertension [19], diabetes with compli-
cations [17,25] and peripheral vascular disease [20].
Reasons for the discordance of comorbidity assign-
ment from both sources of information have been
offered. Romano et al [24] and Powell et al [21] found
that conditions which were asymptomatic tended to be
under-reported in administrative data. Iezzoni et al [18]
suggested that some acute medical conditions or com-
plications were deemed by coders to be more important
than others, thereby creating coding bias.
Humphries et al [25] found that although the agree-
ment between comorbdities from two different sources
as measured by kappa statistics was only fair, there was
no significant difference in the predictive value for all-
cause mortality in a group of patients who have under-
gone percutaneous coronary intervention. Newschaffer
et al [29] found similar results in a population of
patients with breast cancer. Van Doorn [32] showed the
same findings in a population of older adults. Susser et
al [33] found that the Charlson Comorbidity Index
(CCI) [16] constructed with comorbidities obtained
from either administrative data or self-report had similar
predictive validity for functional decline and health ser-
vices utilization.
To date, there has not been any study that identified
patient characteristics associated with the likelihood of
over- or under-reporting of comorbidities in administra-
tive data, particularly in older populations where the
prevalence of comorbidities is higher. This study aimed
to (a) quantify the agreement between administrative
data and medical charts review across a set of comor-
bidities in older hospitalized persons; and (b) examine
the factors associated with under- or over-reporting of
comorbidities by the administrative data. We hypothe-
sized that patients with high number of comorbidities
were more likely to have under-reporting of comorbid-
ities in the administrative data, while those who had
longer lengths of hospital stay were more likely to have
over-reporting.
Methods
Study population
The study population comprised patients aged 55 years
and above who were hospitalized for pneumonia
between 1 January and 31 December 2007 at 3 acute
care hospitals in Singapore. They were identified from
hospital administrative data of the National Healthcare
Group (NHG) Operations Data Store (ODS) through
the coding classification of the Australian National Diag-
nosis Related Groups (AN-DRG) version 3.1. Those
assigned to DRG170 (Respiratory infections/inflamma-
tions age > 54 with complications) and DRG171
(Respiratory infections/inflammations age > 54 without
complications or age < 55 with complications) were
included. In addition, patients with DRG003 (Tracheost-
omy except for mouth, larynx or pharynx disorder age
>15) were checked against their respective International
Classification of Diseases, 9
th Revision, Clinical Modifi-
cation (ICD-9CM) codes for pneumonia. Those with
primary ICD-9CM codes of 481, 482, 485, and 486 were
also included. In Singapore, primary diagnosis refers to
the reason for admission. Patients admitted for pneumo-
nia were selected for this study as it is an acute medical
condition, and not a comorbidity.
Data collection
Information was obtained from two sources, namely
medical charts and routine hospital administrative data.
For medical charts, data was extracted from the emer-
gency department notes, inpatient notes, and specialist
consultation letters by a trained research nurse. Ten
percent of the medical charts were reviewed by the
author to check for consistency. A data collection form
was used to record information on demographic charac-
teristics (age, gender, and ethnic group), hospitalization
(length of stay, comorbidities, and hospital admissions
in the previous 90 days), physical examination (altered
mental status, respiratory rate, and blood pressure) and
selected laboratory data (serum urea level). For comor-
bidities, the set of 30 conditions listed by Elixhauser et
al [34] was used, with the exception of Human Immu-
nodeficiency Virus (HIV) infection because the medical
charts of patients with HIV were not available for
review. Only those documented by the attending physi-
cians during the first 24 hours of admission were
included to ensure that complications occurring during
the course of the hospital stay were excluded. The
research nurse who performed data extraction from
medical charts was blinded to information from the hos-
pital administrative data.
For administrative data, only secondary codes for each
index admissions selected were used without ‘looking
back’ at previous admissions. Secondary or additional
ICD-9CM codes were extracted from the administrative
databases and mapped to the 29 comorbidities. These
ICD-9CM codes were entered into the hospital adminis-
trative databases by trained clinical coders after patients
were discharged. There was no limit to the number of
codes in the secondary diagnoses field. The clinical
coders in the hospitals were a mix of non-practicing
physicians as well as professionally trained coders with
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cal coders were trained by expert coders and the coding
practice adheres to the Singapore Coding Directive, a
national coding standard. The coding accuracy is moni-
tored through periodic and stringent audits by the Min-
istry of Health of Singapore for the purpose of funding/
reimbursement that is DRG-based and hence dependent
on comorbities reported. All comorbidities reflected by
secondary ICD-9CM codes in the routine administrative
data were included.
A total of 29 comorbidities were included. Comorbid-
ities derived from medical charts were considered the
reference ("gold standard”). Each comorbidity derived
from administrative database was re-coded to specify if
it was under-reported or over-reported compared to the
“gold standard”. The total number of comorbidity com-
parisons was the number of hospital episodes multiplied
by the 29 comorbidities.
Mortality is an important outcome and an indicator of
quality of care for patients with pneumonia. Prediction
tools are used to predict and stratify patients’ mortality
risk and a means for deciding on the course of clinical
management. For this study, selected clinical data to
construct the CURB (Confusion, Urea > 7 mmol/L,
Respiratory rate > 30/min, Blood pressure with low sys-
tolic <90 or diastolic <60 mmHg) score to stratify pneu-
monia severity by risk of death [35] were also collected.
A score of 0-1 predicts lowest risk of mortality and a
score of 4 predicts the highest risk.
Data analysis
The unit of analysis was hospital episode. Agreement
between the two sources of data was quantified using
Cohen’s kappa coefficient, . Kappa value above 0.75 indi-
cates an excellent level of agreement beyond chance, 0.40
through 0.75 represent fair to good agreement, and kappa
value less than 0.4 indicates poor agreement [36]. Sensitiv-
ity, specificity, positive predictive value (PPV) and negative
predictive value (NPV) were calculated for each comorbid
condition. Sensitivity was defined as the proportion of
medical charts with documentation of the comorbidity
that was also coded with that comorbidity in the hospital
administrative data. Hospital episodes where comorbidities
that were documented in the medical charts but were not
coded in the hospital administrative data were assigned as
under-reporting. Specificity was defined as the proportion
of medical charts without documentation of the comor-
bidity which was not coded with that condition in the hos-
pital administrative data too. Hospital episodes where
comorbidities that were not documented in the medical
charts but were coded in the hospital administrative data
were assigned as over-reporting.
Multinomial regression was performed to identify
factors that were associated with over-reporting of
comorbidities for all comparisons, followed by for each
of the 29 comorbidities in turn. This process was
repeated for under-reporting of comorbidities. The inde-
pendent variables included age, gender, disease severity,
number of comorbidities, previous hospital admissions
within the last 90days, length of hospital stay, and
inhospital death. Odds ratios for these factors were
obtained for both over- and under-reporting with the
reference being same-coding. Hierarchical multinomial
regression modeling was performed for these analyses
using the STATA program for generalized linear latent
and mixed models (GLLAMM) [37]. This is to account
for the effect of clustering due to multiple hospital epi-
sodes for the same patient during the study period.
All statistical tests were carried out using the STATA
version 9.2 (Stata Corp, College Station, Texas). Statisti-
cal significance was taken at p-values of less than 0.05.
The study was approved by the National Healthcare
Group’s Institutional Review Board.
Results
A total of 3517 hospital admissions for pneumonia that
satisfied the criteria for the study population were iden-
tified. Of these, 46 admissions (1.3%) were excluded
from the study as their medical charts were not available
during the period of review (Figure 1). The characteris-
tics of the remaining 3471 admissions are summarized
in Table 1.
Table 2 shows the prevalence of the comorbidities
obtained from medical charts and administrative data,
and the agreement between both data sources. The pre-
valence of comorbidities obtained from medical charts
review and administrative data ranged from 0.1 to
59.6 percent and 0.3 to 34.3 percent, respectively. The
prevalence rates of all comorbidities derived from medi-
cal charts were higher than that obtained from routine
administrative databases except for diabetes with com-
plications, coagulopathy, deficiency anemias, weight loss,
All hospital discharges, aged 55 years 
and above, between 1 January and 31 
Dec 2007 with DRG170, DRG171 and 
DRG003 (with selected primary ICD 
codes) 
Medical charts reviewed 
Admitted for lung biopsy in day surgery 
Unable to retrieve medical charts 
Medical charts missing 
3,517 
2 
8 
36
3,471 
Figure 1 Study flow diagram.
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were not coded in the administrative data for any of the
cases reviewed. The number of secondary diagnoses
coded in the administrative database for each case range
from 0 to 21, with a median of 6 diagnoses.
The overall agreement between both data sources
using kappa statistics ranged widely from 0.01 (poor
agreement) to 0.78 (excellent agreement). Diabetes
mellitus (uncomplicated and complicated), metastatic
cancer, chronic pulmonary disease, lymphoma and alco-
hol abuse reported the highest kappa statistic values of
0.53 to 0.78.
Table 3 shows the sensitivity, specificity, positive pre-
dictive value and negative predictive values. There were
6 comorbidities with sensitivity of more than 50 percent.
Those that were most under-reported were peptic ulcer
disease, renal failure, depression, paralysis and psy-
choses, with sensitivity of less than 9 percent. The speci-
ficity of the comorbidities was good, with only 6
comorbidities having specificity of less than 96%. These
conditions were deficiency anemias, fluid and electrolyte
disorders, coagulopathy, hypertension, chronic pulmon-
ary disease, and uncomplicated diabetes, and represent
conditions most over-reported in the administrative
data. The positive predictive values (PPV) for the
comorbidities ranged from 0.8 to 94.4 percent. The
negative predictive values (NPV) for all the comorbid-
ities were more than 80 percent, except for hypertension
(58.6%).
There were 100,659 comorbidity comparisons available
for analyses. In the multinomial regression analysis, fac-
tors that were significantly associated with over-reporting
were increased length of stay, disease severity and inhos-
pital death. Factors that were significant for under-
reporting were number of comorbidities, age and hospital
admission in the previous 90 days (Table 4).
Increasing number of concomitant comorbidities and
inhospital death increased the likelihood of over-reporting
for several out of 10 individual comorbidities among the
Elixhauser list (Table 5). Higher number of concurrent
comorbidities consistently increased the likelihood of
under-reporting across all the selected comorbidities,
while increasing age and hospitalization in the previous
90 days did so for several of them (Table 6).
Hierarchical modeling obtained very similar odds
ratios and their 95% confidence intervals for factors
explaining over- and under-reporting of comorbidities
by the administrative data.
Discussion
To the best of our knowledge, this is the first study that
has evaluated the reliability of secondary diagnoses in the
administrative data as a surrogate for comorbidities in
Singapore. The results were consistent with other studies
where the prevalence of comorbidities obtained from
administrative data was lower than that obtained from
medical charts for most conditions [17,19-21,24,38-40].
This is despite the fact that both the research nurse who
abstracted information from medical charts and the clini-
cal coders responsible for assigning the ICD-9CM codes
in the administrative database had obtained their infor-
mation from the same source. The discordance can be
explained by examining the reasons for which the infor-
mation was collected. Pre-existing conditions were docu-
mented in medical charts to assist clinicians in clinical
care decisions. Secondary diagnoses codes from adminis-
trative data do not differentiate between pre-existing
conditions or complications that occurred during the
hospitalization [41]. There is no flag in the administrative
data indicating that the conditions existed on or
after admission. Therefore, conditions such as fluid and
electrolyte disorders, deficiency anemias, blood loss
anemia, diabetes with complications, and coagulopathy
reported higher prevalence rates in administrative data
than in medical charts because it is highly likely that
these conditions arose during hospitalization as a
result of worsening medical condition, complications
of treatment, or confirmation of new medical condi-
tions through laboratory tests. Clinical coders extract
Table 1 Patient characteristics (n = 3471)
Characteristic
Mean age, years (SD) 77.3 (10.8)
Male gender, n (%) 1885 (54.3)
Nursing home residents, n (%) 675 (19.5)
Ethnic group, n (%)
Chinese 2721 (78.4)
Malay 373 (10.7)
Indian 225 (6.5)
Others 152 (4.4)
No. of Elixhauser comorbid conditions, n (%)
0 258 (7.4)
1-2 1544 (44.5)
3-4 1263 (36.4)
5-6 367 (10.6)
7-8 34 (1.0)
9-10 5 (0.1)
>10 0 (0)
Hospital admission in the previous 90 days, n (%) 440 (12.7)
CURB* score, n (%)
0 1544 (44.5)
1 1399 (40.3)
≥2 528 (15.2)
Mean length of stay, days (SD) 9.8 (12.4)
Death in hospital, n (%) 693 (20.0)
*CURB = Constructed from 4 “core” adverse prognostic features: Confusion,
Urea, Respiratory rate, Blood pressure [35].
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more likely to include any conditions that have an
impact on the utilization of resources during the epi-
sode of hospitalization. Hence, these conditions would
be coded as secondary diagnoses in the administrative
data, whilst the research nurse abstracting the informa-
tion from the medical charts would have excluded
them. If these conditions were used in risk adjustment
to compare outcomes, these could potentially cause an
“over-adjustment” of risk [42-48]. On the other hand,
chronic conditions such as depression, psychoses, pep-
tic ulcer disease, paralysis, or renal failure [49] were
under-reported. These conditions may not have been
active problems during hospitalization for pneumonia
and therefore, did not contribute to increased resource
utilization. It is most likely that the patients with his-
tory of drug abuse as documented in the medical
charts, were no longer receiving treatment for it, and
the condition would not be coded by the clinical
coders. Similarly, obesity was not coded as a secondary
d i a g n o s i sa st h ep a t i e n t sw e r en o tl i k e l yt oh a v e
received treatment for obesity during their hospitaliza-
tion for pneumonia.
The kappa statistics for diabetes (uncomplicated and
complicated), metastatic cancer and COPD showed sub-
stantial agreement, as was found in other studies
[17,21,25]. Similarly, Quan and colleagues [40] reported
that comorbidities obtained from ICD-9-CM data had
sensitivity ranging from 9.3% to 83.1%. The wide range
for PPV was a reflection of the different prevalence rates
for individual comorbidities. Paralysis, blood loss anemia
and weight loss with the lowest PPV had the lowest pre-
valence in the medical charts as well.
Factors associated with over-reporting were length of
hospitalization, severity of illness, and inhospital death.
This is not unexpected as these factors were likely to be
associated with an increase in the number of investiga-
tions and interventions during the hospital episode,
Table 2 Prevalence of comorbidities and agreement between data derived from medical charts and administrative
data (n = 3471)
Comorbidities Medical charts No. (%) Administrative data No. (%) Kappa (95% CI)
Diabetes, uncomplicated 996 (28.7) 900 (25.9) 0.78 (0.77 - 0.80)
Metastatic cancer 116 (3.3) 112 (3.2) 0.71 (0.70 - 0.73)
Diabetes, complicated 203 (5.8) 256 (7.4) 0.69 (0.67 - 0.71)
Chronic pulmonary disease 561 (16.2) 417 (12.0) 0.54 (0.53 - 0.56)
Lymphoma 20 (0.6) 17 (0.5) 0.54 (0.52 - 0.56)
Alcohol abuse 33 (1.0) 23 (0.7) 0.53 (0.52 - 0.55)
Hypertension 2068 (59.6) 1190 (34.3) 0.45 (0.44 - 0.47)
Peripheral vascular disorders 199 (5.7) 94 (2.7) 0.44 (0.43 - 0.46)
Liver disease 109 (3.1) 57 (1.6) 0.43 (0.42 - 0.45)
Congestive heart failure 469 (13.5) 252 (7.3) 0.40 (0.39 - 0.42)
RA/Collagen vascular disease 43 (1.2) 12 (0.3) 0.36 (0.35 - 0.37)
Cardiac arrhythmias 489 (14.1) 222 (6.4) 0.34 (0.33 - 0.36)
Coagulopathy 118 (3.4) 271 (7.8) 0.33 (0.32 - 0.35)
Hypothyroidism 118 (3.4) 40 (1.2) 0.33 (0.32 - 0.35)
Other neurological disorders 426 (12.3) 142 (4.1) 0.33 (0.31 - 0.34)
Solid tumor without metastasis 363 (10.5) 200 (5.8) 0.32 (0.30 - 0.34)
Fluid and electrolyte disorders 942 (27.1) 712 (20.5) 0.32 (0.30 - 0.33)
Deficiency anemias 474 (13.7) 704 (20.3) 0.28 (0.26 - 0.29)
Valvular disease 98 (2.8) 38 (1.1) 0.21 (0.19 - 0.22)
Pulmonary circulation disorders 44 (1.3) 16 (0.5) 0.20 (0.18 - 0.21)
Psychoses 97 (2.8) 13 (0.4) 0.14 (0.13 - 0.15)
Weight loss 18 (0.5) 82 (2.4) 0.13 (0.12 - 0.15)
Depression 319 (9.2) 33 (1.0) 0.08 (0.07 - 0.09)
Renal failure 447 (12.9) 24 (0.7) 0.06 (0.05 - 0.07)
Peptic ulcer disease 174 (5.0) 16 (0.5) 0.05 (0.04 - 0.05)
Blood loss anemia 3 (0.1) 57 (1.6) 0.03 (0.02 - 0.04)
Paralysis 16 (0.5) 128 (3.7) 0.01 (-0.01 - 0.02)
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Page 5 of 9Table 3 Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of comorbidities
(n = 3471)
Comorbidities Sensitivity Specificity Positive Predictive Value Negative Predictive Value
% 95% CI % 95% CI % 95% CI % 95% CI
Diabetes, complicated 80.3 74.2 - 85.5 97.2 96.5 - 97.7 63.7 57.5 - 69.6 98.8 98.3 - 99.1
Diabetes, uncomplicated 80.1 77.5 - 82.6 95.9 95.0 - 96.6 88.7 86.4 - 90.7 92.3 91.2 - 93.3
Metastatic cancer 70.7 61.5 - 78.8 99.1 98.7 - 99.4 73.2 64.0 - 78.8 99.0 98.6 - 99.3
Coagulopathy 60.2 50.8 - 69.1 94.0 93.2 - 94.8 26.2 21.1 - 31.9 98.5 98.1 - 98.9
Hypertension 54.3 52.1 - 56.5 95.2 94.0 - 96.3 94.4 92.9 - 95.6 58.6 56.5 - 60.6
Chronic pulmonary disease 52.8 48.5 - 57.0 95.8 95.1 - 96.5 71.0 66.4 - 75.3 91.3 90.3 - 92.3
Lymphoma 50.0 27.2 - 72.8 99.8 99.6 - 99.9 58.8 32.9 - 81.6 99.7 99.5 - 99.9
Deficiency anemias 49.2 44.6 - 53.8 84.3 82.9 - 85.6 33.1 29.6 - 36.7 91.3 90.2 - 92.3
Alcohol abuse 45.5 28.1 - 63.7 99.8 99.5 - 99.9 65.2 42.7 - 83.6 99.5 99.2 - 99.7
Fluid and electrolyte disorders 41.8 38.7 - 45.1 87.4 86.1 - 88.7 55.3 51.6 - 59.0 80.1 78.6 - 81.6
Weight loss 38.9 17.3 - 64.3 97.8 97.3 - 98.3 8.5 3.5 - 16.8 99.7 99.4 - 99.8
Congestive heart failure 35.4 31.1 - 39.9 97.1 96.5 - 97.7 65.9 59.7 - 71.7 90.6 89.5 - 91.6
Peripheral vascular disorders 34.2 27.6 - 41.2 99.2 98.8 - 99.5 72.3 62.2 - 81.1 96.1 95.4 - 96.8
Liver disease 33.9 25.2 - 43.6 99.4 99.1 - 99.6 64.9 51.1 - 77.1 97.9 97.4 - 98.4
Blood loss anemia 33.3 0.8 - 90.6 98.4 97.9 - 98.8 1.8 0.0 - 9.4 99.9 99.8 - >99.9
Cardiac arrhythmias 29.0 25.1 - 33.3 97.3 96.7 - 97.9 64.0 57.3 - 70.3 89.3 88.2 - 90.4
Solid tumor without metastasis 28.7 24.1 - 33.6 96.9 96.2 - 97.5 52.0 44.8 - 59.1 92.1 91.1 - 93.0
Other neurological disorders 24.7 20.6 - 29.0 98.8 98.3 - 99.1 73.9 65.9 - 80.9 90.4 89.3 - 91.3
Rheumatoid Arthritis/Collagen vascular disease 23.3 11.8 - 38.6 99.9 99.8 - >99.9 83.3 51.6 - 97.9 99.1 98.7 - 99.3
Hypothyroidism 22.9 15.7 - 31.5 99.6 99.3 - 99.8 67.5 50.9 - 81.4 97.4 96.8 - 97.9
Valvular disease 15.3 8.8 - 24.0 99.3 99.0 - 99.6 39.5 24.0 - 56.6 97.6 97.0 - 98.1
Pulmonary circulation disorders 13.6 5.2 - 27.4 99.7 99.5 - 99.9 37.5 15.2 - 64.6 98.9 98.5 - 99.2
Psychoses 8.3 3.6 - 15.6 99.9 99.7 - >99.9 61.5 31.6 - 86.1 97.4 96.8 - 97.9
Paralysis 6.3 0.2 - 30.2 96.3 95.6 - 96.9 0.8 0.0 - 4.3 99.6 99.3 - 99.8
Depression 5.0 2.9 - 8.0 99.5 99.1 - 99.7 48.5 30.8 - 66.5 91.2 90.2 - 92.1
Renal failure 3.8 2.2 - 6.0 99.8 99.5 - 99.9 70.8 48.9 - 87.4 87.5 86.4 - 88.6
Peptic ulcer disease 2.9 0.9 - 6.6 99.7 99.4 - 99.8 31.3 11.0 - 58.7 95.1 94.3 - 95.8
Table 4 Multinomial regression to determine factors that are associated with over-reporting and under-reporting of
comorbidity (n = 100659)
Explanatory variable Odds Ratio (95% confidence interval)
Over-reporting vs. same-reporting Under-reporting vs. same-reporting
Age (per year) 1.003 (0.999 - 1.007) 1.010 (1.007 - 1.013)*
Male gender 1.009 (0.924 - 1.103) 1.057 (0.997 - 1.121)
Hospital admission in the previous 90 days 0.974 (0.879 - 1.079) 1.108 (1.039 - 1.182)*
Number of co-morbid conditions 1.013 (0.984 - 1.044) 1.443 (1.418 - 1.469)*
CURB score:
0 (reference) 1.000 1.000
1 1.352 (1.219 - 1.500)* 1.109 (1.035 - 1.187)*
≥ 2 1.488 (1.303 - 1.700)* 1.058 (0.966 - 1.158)
Length of hospital stay (per day) 1.013 (1.011 - 1.015)* 1.000 (0.997 - 1.002)
Death in hospital 1.028 (1.118 - 1.379)* 1.028 (0.958 - 1.103)
* Statistical significance at p-value < 0.05.
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ditions and complications. These conditions were more
likely to be coded as secondary diagnoses in the admin-
istrative data because they were related to increased
resource utilization. Other researchers have previously
found that some medical conditions or complications of
treatment were judged more important than other
chronic conditions when patients were critically ill or
when they died [18,21,23,50].
Age, previous hospital admission and number of
comorbidities were associated with under-reporting of
comorbidities in the administrative database., Although
there is no limit to the number of secondary diagnoses
that can be coded, having a higher number of concur-
rent comorbidities may result in less important comor-
bidities being disregarded. Advancing age [8] and recent
hospitalization are themselves associated with increased
number of comorbidities. The association of these two
factors with under-reporting may be a reflection of resi-
dual confounding of number of comorbidities that is
not accounted for due to the specification of our regres-
sion models.
For the individual comorbidities, the same factors
associated with over- or under-reporting for the whole
study population were represented for most of the
important ones we selected for detailed analyses. This
was most clearly seen with number of concurrent
comorbidities being associated with under-reporting for
all 10 conditions. For length of hospitalization, severity
of illness, inhospital death, age, and hospital admission
in the previous 90 days, smaller sample sizes or lack of
true effect may have accounted for the absence of asso-
ciation observed for some comorbidities. Nevertheless,
we argue that the overall picture supports the results for
the whole study population.
The main strength of this study is its large sample
size. In addition, as there is no limit to the number of
secondary diagnoses that can be coded in the adminis-
trative data, it is unlikely that the lower prevalence of
comorbidities in the administrative data were due to
restrictions imposed by the prevailing health informa-
tion system.
There are several limitations of the study. Firstly, the
findings of this study may not be generalized to older
Table 5 Factors associated with over-reporting of 10 selected comorbidities
Age Previous admission No of comorbidities Length of stay Severity of illness Death
Metastatic cancer + + +
Solid tumour without mestastases + +
Chronic heart failure + + + +
Renal failure + +
Chronic pulmonary disease +
Peripheral vascular disease + +
Hypertension +
DM uncomplicated + +
DM complicated +
Deficiency anaemia + + +
+: denotes a positive association that is statistically significant (p-value < 0.05).
Table 6 Factors associated with under-reporting of 10 selected comorbidities
Age Previous admission Male No of comorbidities Length of stay Severity of illness
Solid tumour without mestastases + +
Liver disease + + +
Chronic heart failure + + + +
Renal failure + + + + +
Chronic pulmonary disease + +
Peripheral vascular disease + +
Hypertension + +
DM uncomplicated + + +
DM complicated +
Deficiency anaemia + +
+: denotes a positive association that is statistically significant (p-value < 0.05).
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Page 7 of 9patients hospitalized for other acute illnesses because we
only studied those with pneumonia. The use of DRG
codes for pneumonia to identify cases could have
included cases that did not meet the BTS criteria for
pneumonia as DRG codes were assigned to reflect
resource utilization. However, as the main objectives of
this study were to compare the comorbidities obtained
from two sources, and to identify the possible factors
that may be associated with under or over-reporting of
the comorbidities, and not on the outcomes for patients
with pneumonia, the inclusion of such was not likely to
have affected the findings. Secondly, documentation of
comorbidities in the medical charts within the first 24
hours of admission may be incomplete in a busy ward
environment with many patients waiting to be reviewed
and therefore, may not be the ideal “gold standard”
where comorbidities are concerned. To address this, we
ensured that the research nurse was familiar with docu-
mentation in the medical charts and was trained to
abstract very specific conditions. Attending physicians
also had access to an electronic medical records system
that contained information on known comorbidities.
Therefore, we believe that the likelihood of documenta-
tion of important comorbidities being omitted is low.
Thirdly, this study involved documentation of comor-
bidities in a single health care system and may not
necessarily mirror the situation in other systems.
Further research on factors associated with under- and
over-reporting of comorbidities by administrative data
in other health systems is needed to confirm our find-
ings. Fourthly, we acknowledge that there may be other
factors that could be associated with over- or under-
reporting of the comorbidities but were not measured in
our study. Although there were little prior research on
this subject to guide us, we have included plausible fac-
tors on the basis of clinical opinion.
Conclusions
Our study confirmed that the prevalence of almost all
comorbidities obtained from administrative data was
lower than that obtained from medical chart review.
The validity of secondary diagnoses from administrative
data varies with the specific comorbidity in question,
and is influenced by factors such as age, number of
comorbidities, hospital admission in the preceding 90
days, severity of illness, length of hospitalization, and
whether inhospital death occurred. While some comor-
bidities were reported as secondary diagnoses with a
reasonable level of accuracy, there were several that may
not be used interchangeably. Researchers should be cau-
tious and take these findings into account when using
this source of information as an alternative to medical
chart reviews for the purpose of measuring comorbidity
burden. This may also affect policy decisions by hospital
administrators as it may underestimate the true burden
of illnesses. Further research is needed to confirm our
findings in other patient populations.
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